Stress-Induced Alterations of Mesocortical and Mesolimbic
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Neuromodulators and Long-Term Synaptic Plasticity in Learning and Memory: a Steered-Glutamatergic Perspective
brain sciences Review Neuromodulators and Long-Term Synaptic Plasticity in Learning and Memory: A Steered-Glutamatergic Perspective Amjad H. Bazzari * and H. Rheinallt Parri School of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK; [email protected] * Correspondence: [email protected]; Tel.: +44-(0)1212044186 Received: 7 October 2019; Accepted: 29 October 2019; Published: 31 October 2019 Abstract: The molecular pathways underlying the induction and maintenance of long-term synaptic plasticity have been extensively investigated revealing various mechanisms by which neurons control their synaptic strength. The dynamic nature of neuronal connections combined with plasticity-mediated long-lasting structural and functional alterations provide valuable insights into neuronal encoding processes as molecular substrates of not only learning and memory but potentially other sensory, motor and behavioural functions that reflect previous experience. However, one key element receiving little attention in the study of synaptic plasticity is the role of neuromodulators, which are known to orchestrate neuronal activity on brain-wide, network and synaptic scales. We aim to review current evidence on the mechanisms by which certain modulators, namely dopamine, acetylcholine, noradrenaline and serotonin, control synaptic plasticity induction through corresponding metabotropic receptors in a pathway-specific manner. Lastly, we propose that neuromodulators control plasticity outcomes through steering glutamatergic transmission, thereby gating its induction and maintenance. Keywords: neuromodulators; synaptic plasticity; learning; memory; LTP; LTD; GPCR; astrocytes 1. Introduction A huge emphasis has been put into discovering the molecular pathways that govern synaptic plasticity induction since it was first discovered [1], which markedly improved our understanding of the functional aspects of plasticity while introducing a surprisingly tremendous complexity due to numerous mechanisms involved despite sharing common “glutamatergic” mediators [2]. -
Multiplexed Neurochemical Signaling by Neurons of the Ventral Tegmental
Journal of Chemical Neuroanatomy 73 (2016) 33–42 Contents lists available at ScienceDirect Journal of Chemical Neuroanatomy journal homepage: www.elsevier.com/locate/jchemneu Multiplexed neurochemical signaling by neurons of the ventral tegmental area David J. Barker, David H. Root, Shiliang Zhang, Marisela Morales* Neuronal Networks Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, 251 Bayview Blvd Suite 200, Baltimore, MD 21224, United States A R T I C L E I N F O A B S T R A C T Article history: The ventral tegmental area (VTA) is an evolutionarily conserved structure that has roles in reward- Received 26 June 2015 seeking, safety-seeking, learning, motivation, and neuropsychiatric disorders such as addiction and Received in revised form 31 December 2015 depression. The involvement of the VTA in these various behaviors and disorders is paralleled by its Accepted 31 December 2015 diverse signaling mechanisms. Here we review recent advances in our understanding of neuronal Available online 4 January 2016 diversity in the VTA with a focus on cell phenotypes that participate in ‘multiplexed’ neurotransmission involving distinct signaling mechanisms. First, we describe the cellular diversity within the VTA, Keywords: including neurons capable of transmitting dopamine, glutamate or GABA as well as neurons capable of Reward multiplexing combinations of these neurotransmitters. Next, we describe the complex synaptic Addiction Depression architecture used by VTA neurons in order to accommodate the transmission of multiple transmitters. Aversion We specifically cover recent findings showing that VTA multiplexed neurotransmission may be mediated Co-transmission by either the segregation of dopamine and glutamate into distinct microdomains within a single axon or Dopamine by the integration of glutamate and GABA into a single axon terminal. -
Midbrain Dopaminergic and Gabaergic Neurons' Responses To
Institute of Zoology and Biomedical Research Topic: Midbrain dopaminergic and GABAergic neurons' responses to the aversive stimulus across alternating brain states of urethane anaesthetized rat - electrophysiological in vivo studies. Supervisor: dr hab. Tomasz Błasiak (Department of Neurophysiology and Chronobiology) [email protected] Background information: Ventral tegmental area (VTA) is one of the main sources of dopamine (DA) in the mammalian brain. This structure is the centre of dopaminergic pathways and plays a key role in regulation of motivation (Wise, 2005), goaldirected behaviours, reinforcement learning or reacting to reward-related cues (Schultz, 1997; Morita, 2013). Better understanding of how DA circuits work and are modulated can contribute to explanation of mechanisms of dysfunctions laying at the root of some nervous system disorders such as addiction, anxiety, PTSD or some of depression symptoms (anhedonia or lack of motivation). It has been shown that, occurrence of unexpected reward, reward-related cue or novelty causes phasic release of DA in VTA target structures (Goto et al, 2007). Those phasic changes in DA neurons activity lie at the root of forming reward prediction error (RPE) signal which encodes difference between expected and delivered reward - updating reward expectations and forming the basis for learning (Schultz, 2016). DA neurons also code response to the aversive or noxious stimuli by development of quick, short latency pause in firing. For a long time, it has been assumed that DA neurons code both reward and aversive stimuli homogenously across the entire dopaminergic neurons population forming positive and negative prediction error signals respectively (Schultz, 1998; Ungless et al., 2004). -
Optogenetic Activation of Dopamine Neurons in the Ventral Tegmental Area Induces Reanimation from General Anesthesia
CORE Metadata, citation and similar papers at core.ac.uk Provided by DSpace@MIT Optogenetic activation of dopamine neurons in the ventral tegmental area induces reanimation from general anesthesia Norman E. Taylora,b,c, Christa J. Van Dorta,b,c, Jonathan D. Kennya,c, JunZhu Peia,c, Jennifer A. Guideraa,c, Ksenia Y. Vlasova,c, Justin T. Leea,c, Edward S. Boydenc,d,e,f, Emery N. Browna,b,c,g,h,1,2, and Ken Solta,b,c,1 aDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA 02114; bDepartment of Anaesthesia, Harvard Medical School, Boston, MA 02114; cDepartment of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; dMedia Lab, Massachusetts Institute of Technology, Cambridge, MA 02139; eMcGovern Institute, Massachusetts Institute of Technology, Cambridge, MA 02139; fDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; gThe Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139; and hInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139 Contributed by Emery N. Brown, September 14, 2016 (sent for review February 29, 2016; reviewed by Loren M. Frank, Robert W. Gereau, and Andrew Jenkins) Dopamine (DA) promotes wakefulness, and DA transporter inhibi- There are currently no clinically approved pharmacologic or cir- tors such as dextroamphetamine and methylphenidate are effective cuit-level interventions that can induce active emergence or for increasing arousal and inducing reanimation, or active emer- reanimation from general anesthesia (10). Dopamine (DA) is a gence from general anesthesia. DA neurons in the ventral tegmental neurotransmitter that is well-known to elicit wakefulness (11). -
Dopaminergic Microtransplants Into the Substantia Nigra of Neonatal Rats with Bilateral 6-OHDA Lesions
The Journal of Neuroscience, May 1995, 15(5): 3548-3561 Dopaminergic Microtransplants into the Substantia Nigra of Neonatal Rats with Bilateral 6-OHDA Lesions. I. Evidence for Anatomical Reconstruction of the Nigrostriatal Pathway Guido Nikkhah,1,2 Miles G. Cunningham,3 Maria A. Cenci,’ Ronald D. McKay,4 and Anders Bj6rklund’ ‘Department of Medical Cell Research, University of Lund, S-223 62 Lund, Sweden, *Neurosurgical Clinic, Nordstadt Hospital, D-301 67 Hannover, Germany, 3Harvard Medical School, Boston, Massachusetts 02115, and 4 Laboratory of Molecular Biology, NINDS NIH, Bethesda, Maryland 20892 Reconstruction of the nigrostriatal pathway by long axon [Key words: target reinnervation, axon growth, neural growth derived from dopamine-rich ventral mesencephalic transplantation, tyrosine hydroxylase immunohistochem- (VM) transplants grafted into the substantia nigra may en- istry, Fos protein, Fluoro-Gold] hance their functional integration as compared to VM grafts implanted ectopically into the striatum. Here we report on In the lesioned brain of adult recipients dopamine-rich grafts a novel approach by which fetal VM grafts are implanted from fetal ventral mesencephalon (VM) are unable to reinner- unilaterally into the substantia nigra (SN) of 6-hydroxydo- vate the caudate-putamen unless they are placed close to, or pamine (SOHDA)-lesioned neonatal pups at postnatal day within, the denervated target structure (BjGrklund et al., 1983b; 3 (P3) using a microtransplantation technique. The results Nikkhah et al., 1994b). The failure of regenerating dopaminergic demonstrate that homotopically placed dopaminergic neu- axons to reinnervate the striatum from more distant implantation rons survive and integrate well into the previously sites, including their normal site of origin, the substantia nigra 6-OHDA-lesioned neonatal SN region. -
Prominence of the Dopamine D2 Short Isoform in Dopaminergic Pathways
Proc. Natl. Acad. Sci. USA Vol. 95, pp. 7731–7736, June 1998 Neurobiology Prominence of the dopamine D2 short isoform in dopaminergic pathways ZAFAR U. KHAN*†,LADISLAV MRZLJAK*, ANTONIA GUTIERREZ‡,ADELAIDA DE LA CALLE‡, AND PATRICIA S. GOLDMAN-RAKIC* *Section of Neurobiology, Yale University School of Medicine, New Haven, CT 06510; and ‡Department of Cell Biology, University of Malaga, Malaga 29071, Spain Contributed by P. S. Goldman-Rakic, April 15, 1998 ABSTRACT As a result of alternative splicing, the D2 gene opment. Affinity purification of the antisera was as described of the dopamine receptor family exists in two isoforms. The D2 elsewhere (12). In brief, peptide (5 mg) was coupled to1gof long is characterized by the insertion of 29 amino acids in the activated thiopropyl-Sepharose 6B (Pharmacia LKB). Phos- third cytoplasmic loop, which is absent in the short isoform. We phate-buffered saline (PBS) diluted antiserum (1:5) was circu- have produced subtype-specific antibodies against both the D2 lated through the column. After washing with PBS, the antibody short and D2 long isoforms and found a unique compartmen- was eluted with glycinezHCl, pH 2.3, and dialyzed against PBS. talization between these two isoforms in the primate brain. The Membrane Preparation. Adult rhesus monkey (Macaca mu- D2 short predominates in the cell bodies and projection axons of latta) brains were used for the preparation of tissue membranes the dopaminergic cell groups of the mesencephalon and hypo- as described earlier (13). Briefly, brain tissues were homogenized thalamus, whereas the D2 long is more strongly expressed by with 10% sucrose in TriszHCl, pH 7.4, and centrifuged at 3,000 neurons in the striatum and nucleus accumbens, structures rpm in a Sorvall for 5 min. -
1 Development of Methods for Measurement of the Integrity Of
Development of Methods for Measurement of the Integrity of Dopaminergic Pathways in a Rat Model of Parkinson’s Disease1 ¢¡¤£¦¥¨§ © ¨ § £ Department of Cognitive Science, Carleton University [email protected] Bruce Hutcheon Department of Neuroscience, Carleton University [email protected] Introduction Parkinson’s disease (PD) is a progressive neurological disorder manifested by difficulty initiating movement, muscular rigidity, resting tremor, and other postural abnormalities. It is associated with a loss of neurons in the midbrain that supply the forebrain with dopamine. The resulting chemical deficit in forebrain structures results in a disruption of integrated motor output. Before a description of the experimental studies is given, an outline of the anatomy and basic operation of the motor circuits is needed. The regions of the brain that participate in voluntary movements are the basal ganglia, motor nuclei of the brain stem, red nucleus, and cerebellum. The region of interest in the case of PD is the basal ganglia. 1. The basal ganglia consists of four subcortical nuclei (see Figure 1): striatum [ST] (a collective term for the caudate nucleus and putamen), 2. globus pallidus (consisting of external [GPe] and internal segments [GPi]), 3. subthalamic nucleus [STN], and 4. substantia nigra [SN] (consisting of the pars compacta [SNc] and pars reticulata [SNr]). 1 Report Carleton University Cognitive Science Technical 2002-08 URL http://www.carleton.ca/iis/TechReports © 2002 Edina ¦ ! "¦#$&%('*)+-, .0/21$,34.05(/0% 1 Figure 1: Coronal section of the basal ganglia (adapted from Nieuwenhuys et al. 1981) These nuclei participate in a feedback loop which begins at the motor cortex, proceeds through the basal ganglia (with the striatum as the input centre), to the thalamus (the main conduit for sensory information reaching the brain), and back to the motor cortex. -
Harnessing Serotonergic and Dopaminergic Pathways for Lymphoma Therapy: Evidence and Aspirations Nicholas M
Seminars in Cancer Biology 18 (2008) 218–225 Review Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: Evidence and aspirations Nicholas M. Barnes a, , John Gordon b a Division of Neuroscience, The Medical School, Vincent Drive, Birmingham B15 2TT, United Kingdom b Division of Immunity & Infection, The Medical School, Vincent Drive, Birmingham B15 2TT, United Kingdom Abstract Growing evidence supports the notion that pharmaceutical targeting of the 5-hydroxytryptamine (5-HT) and dopamine (DA) systems offers the potential to treat human immune system disorders. This review describes this emerging area of research, which has the benefit of being supported by a relatively detailed understanding of these monoamine systems within other tissues of the body. Furthermore, the availability of a number of pharmaceutical agents originally developed to manipulate central monoamine function, offer many suitable drug candidates to test their therapeutic potential in the immune pathology arena. © 2008 Published by Elsevier Ltd. Keywords: Lymphoma; Novel drug targets; Serotonin; Dopamine; Drug reprofiling Contents 1. Introduction ............................................................................................................ 218 2. 5-HT—the serotonergic pathway.......................................................................................... 219 2.1. Synthesis and metabolism of 5-HT.................................................................................. 219 2.2. 5-HT receptors and transporter .................................................................................... -
Ventral Tegmental Area Glutamate Neurons: Electrophysiological Properties and Projections
15076 • The Journal of Neuroscience, October 24, 2012 • 32(43):15076–15085 Cellular/Molecular Ventral Tegmental Area Glutamate Neurons: Electrophysiological Properties and Projections Thomas S. Hnasko,1,2,3,4 Gregory O. Hjelmstad,2,3 Howard L. Fields,2,3 and Robert H. Edwards1,2 Departments of 1Physiology and 2Neurology, University of California San Francisco, San Francisco, California 94143, 3Ernest Gallo Clinic and Research Center, Emeryville, California 94608, and 4Department of Neurosciences, University of California San Diego, La Jolla, California 92093 The ventral tegmental area (VTA) has a central role in the neural processes that underlie motivation and behavioral reinforcement. Although thought to contain only dopamine and GABA neurons, the VTA also includes a recently discovered population of glutamate neurons identified through the expression of the vesicular glutamate transporter VGLUT2. A subset of VGLUT2 ϩ VTA neurons corelease dopamine with glutamate at terminals in the NAc, but others do not express dopaminergic markers and remain poorly characterized. Using transgenic mice that express fluorescent proteins in distinct cell populations, we now find that both dopamine and glutamate neurons in the medial VTA exhibit a smaller hyperpolarization-activated current (Ih ) than more lateral dopamine neurons and less ϩ consistent inhibition by dopamine D2 receptor agonists. In addition, VGLUT2 VTA neurons project to the nucleus accumbens (NAc), lateral habenula, ventral pallidum (VP), and amygdala. Optical stimulation of VGLUT2 ϩ projections expressing channelrhodopsin-2 further reveals functional excitatory synapses in the VP as well as the NAc. Thus, glutamate neurons form a physiologically and anatom- ically distinct subpopulation of VTA projection neurons. Introduction well as to the amygdala, septum, hippocampus, and prefrontal Dopamine neurons of the ventral midbrain are classically divided cortex (PFC) (Fields et al., 2007; Ikemoto, 2007). -
Pharmacology - the Reward Pathway
Pharmacology - The reward pathway All drugs of abuse and dependence share one thing in common. They increase the activity of a neurotransmitter called dopamine in the reward pathway of the brain. Activating this reward pathway, which crosses the limbic region of the brain and connects with the cortex-- that is, it crosses the emotional centre of the brain and connects to the decision-making part of the brain-- will reinforce a behaviour. It does so because it produces a pleasurable feeling. Dopamine is a monoamine. Our mood is affected by the monoamines. There's an association between the altered function of monoamine neurotransmitters such as dopamine in the brain, and disorders such as depression and anxiety. Indeed, drugs that increase the amount of these neurotransmitters are the major medical approach to treating disorders such as depression. Dopamine pathways commence in the brainstem, and project diffusely to the cortex. So that is, they're taking us through parts of the brain associated with feelings, and thoughts, and cognition, and memory, and movement. So dopamine is important in the control of mood and emotion, thought patterns, and the laying down of memories. It's also important in the control of sleep, feeding behaviour, and the control of body temperature. Dopamine is the fuel for intentional behaviours. And it's the fuel for desire. Dopamine says, I want and I desire. Dopamine production is turned on when we're cued by a stimulus paired with a reward, when we're doing something that is good for our survival. For this lecture, there are three main dopamine pathways that we're most interested in. -
Molecular Regulation in Dopaminergic Neuron Development
International Journal of Molecular Sciences Review Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration Floriana Volpicelli 1 , Carla Perrone-Capano 1,2 , Gian Carlo Bellenchi 2,3, Luca Colucci-D’Amato 4,* and Umberto di Porzio 2 1 Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy; fl[email protected] (F.V.); [email protected] (C.P.C.) 2 Institute of Genetics and Biophysics “Adriano Buzzati Traverso”, CNR, 80131 Rome, Italy; [email protected] (G.C.B.); [email protected] (U.d.P.) 3 Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy 4 Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania “Luigi Vanvitelli”, 81100 Caserta, Italy * Correspondence: [email protected]; Tel.: +39-0823-274577 Received: 28 April 2020; Accepted: 1 June 2020; Published: 3 June 2020 Abstract: The relatively few dopaminergic neurons in the mammalian brain are mostly located in the midbrain and regulate many important neural functions, including motor integration, cognition, emotive behaviors and reward. Therefore, alteration of their function or degeneration leads to severe neurological and neuropsychiatric diseases. Unraveling the mechanisms of midbrain dopaminergic (mDA) phenotype induction and maturation and elucidating the role of the gene network involved in the development and maintenance of these neurons is of pivotal importance to rescue or substitute these cells in order to restore dopaminergic functions. Recently, in addition to morphogens and transcription factors, microRNAs have been identified as critical players to confer mDA identity. The elucidation of the gene network involved in mDA neuron development and function will be crucial to identify early changes of mDA neurons that occur in pre-symptomatic pathological conditions, such as Parkinson’s disease. -
Brain Neurotransmitters
Brain Neurotransmitters Prof. Laila Alayadhi Chemical substances released by electrical impulses into the synaptic cleft from synaptic vesicles of presynaptic membrane Diffuses to the postsynaptic membrane Binds to and activates the receptors Leading to initiation of new electrical signals or inhibition of the post-synaptic neuron Prof. Laila Alayadhi Prof. Laila Alayadhi 1- Adrenaline / NE 2- Ach 3- Glutamate 4- GABA 5- Serotonin 6- Dopamine Prof. Laila Alayadhi 1- Norepinephrine System Nucleus Coeruleus in the pons, involved in physiological responses to stress and panic Prof. Laila Alayadhi The Locus Coeruleus/Norepinephrine System • Very wide-spread projection system • LC is activated by stress and co-ordinates responses via projections to thalamus, cortex, hippocampus, amygdala, hypothalamus, autonomic brainstem centers, and the spinal cord • Sleep • Attention/Vigilance Prof. Laila Alayadhi Locus coeruleus neurons fire as a function of vigilance and arousal Irregular firing during quiet wakefulness Sustained activation during stress Their firing decreases markedly during slow-wave sleep and virtually disappears during REM sleep. Prof. Laila Alayadhi Norepinephrine (NE) Implicated in Stress- Related Disorders • Reduced level in: • Depression • Withdrawal from some drugs of abuse (NE imbalance + other NT) • High level in anxiety panic disorder Prof. Laila Alayadhi PGi: Nucleus paragigantocellularis Prof. Laila Alayadhi PrH: Perirhinal Cortex Prof. Laila Alayadhi 2- Acetylcholine Prof. Laila Alayadhi Major neurotransmitter in the